Skip to main content
. 2015 Nov 1;8(11):14932–14938.

Table 3.

c-Met overexpression (measured by IHC) and MET gene amplification (measured by FISH) in a cohort of glioblastoma patients

c-Met IHC MET FISH Total PTEN IHC Total


Amplification No amplification Loss No loss
Positive 7 (5.1%) 11 (8.0%) 18 (13.1%) 1 (0.7%) 7 (5.1%) 8 (5.8%)
Negative 0 119 (86.9%) 119 (86.9%) 19 (13.9%) 110 (80.3%) 129 (94.2%)
Total 7 (5.1%) 130 (94.9%) 137 (100%) 20 (14.6%) 117 (85.4%) 137 (100%)

IHC: immunohistochemistry, FISH: fluorescence in situ hybridization.